Our data indicate that magnolol could increase LPL activity in cells and reduce the plasma triglyceride level in APOA5 c.553G>T variant carrier mice and facilitate triglyceride metabolism in mild hypertriglyceridemia. This evidence concerns the gene APOA5 and hypertriglyceridemia.